Alberta Moving Beyond Breast Cancer (AMBER)
The Alberta Moving Beyond Breast Cancer (AMBER) study is an observational study investigating the effect of lifestyle, including physical activity, on cancer recovery and survivorship in a group of 1,500 newly diagnosed breast cancer survivors. The study recruited participants between 2012 and 2019 and will run until 2030. Participants wore the activPAL for one week on joining the study and again after one and three years to measure physical activity and sedentary behaviour. The collection of physical activity data concluded in 2024. Study Protocol Study Website
British Cohort Study 1970
The 1970 British Cohort Study (BCS70) is a longitudinal study following the lives of approximately 17,000 individuals born in England, Scotland or Wales during a single week in 1970. The study’s age 46 sweep was carried out between 2016 and 2018, with 8,581 members participating. A wide range of data was captured in the sweep, including personal, social and economic data, a range of biomedical measures, and accelerometer derived physical activity data. As part of the study, over 6,000 of the participants wore the activPAL for seven days. Study Protocol Study Website
Maastricht Study
The Maastricht Study is an extensive phenotyping study that focuses on the etiology of type 2 diabetes, its classic complications (cardiovascular disease, nephropathy, neuropathy and retinopathy), and its emerging comorbidities, including cognitive decline, depression, and gastrointestinal, respiratory and musculoskeletal diseases. The study uses advanced state-of-the-art imaging techniques and extensive biobanking to determine health status in a population-based cohort of 10,000 individuals that is enriched with type 2 diabetes participants. As part of the study, participants wore the activPAL for seven days. Study Protocol Study Website